EXELON CORP — Director's Dealing 2022

Nov 1, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: EXELON CORP (EXC)
CIK: 0001109357
Period of Report: 2022-10-28

Reporting Person: Trpik Joseph R JR (SVP & Corp. Controller)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-10-28	Restricted Stock Unit Award (10/28/2022)	$	A	25000	Acquired		Common stock (25000)	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Restricted Stock Unit Award (05/02/2022)	$		Common stock (919)	919	Direct
Restricted Stock Unit Award (01/28/2022)	$		Common stock (2913)	2913	Direct
Restricted Stock Unit Award (01/25/2021)	$		Common stock (2627)	2627	Direct
Restricted Stock Unit Award (01/27/2020)	$		Common stock (1252)	1252	Direct
Earned Performance RSU	$		Common stock (7298)	7298	Direct
Deferred Phantom Shares	$		Common stock (516)	516	Direct

Footnotes

F1: RSU award granted pursuant to the Exelon Long Term Incentive Plan; Award vests in 1/3 increments on the first, second and third anniversary of the grant date referenced in Column 1 subject to the reporting person's continued employment with the company. Each RSU represents the right to receive one share of Exelon common stock upon vesting. Unvested award balance accrues additional units through automatic dividend reinvestment, which vest on the same schedule as the underlying award.

F2: Additional RSU award granted in May 2022 pursuant to the Exelon Long Term Incentive Plan; this award vests in 1/3 increments on the date of the Compensation Committee's January or February meeting in the first, second and third years after the award was granted. Balance includes 13 shares acquired through automatic dividend reinvestment.

F3: Annual RSU award granted in January 2022 pursuant to the Exelon Long Term Incentive Plan; each award vests in 1/3 increments on the date of the Compensation Committee's January or February meeting in the first, second and third years after the award was granted. Balance includes 42 shares acquired through automatic dividend reinvestment.

F4: Remaining 2/3 increment of annual RSU award granted in January 2021 pursuant to the Exelon Long Term Incentive Plan; each award vests in 1/3 increments on the date of the Compensation Committee's January or February meeting in the first, second and third years after the award was granted. Balance includes 38 shares acquired through automatic dividend reinvestment.

F5: Remaining 1/3 increment of annual restricted stock unit (RSU) award granted in January 2020 pursuant to the Exelon Long Term Incentive Plan; each award vests in 1/3 increments on the date of the Compensation Committee's January or February meeting in the first, second and third years after the award was granted. Balance includes 18 shares acquired through automatic dividend reinvestment.

F6: RSU award granted pursuant to the Exelon Long Term Incentive Plan; Award cliff vests at the January 2023 meeting of the Compensation Committee with each RSU representing the right to receive one share of Exelon common stock upon vesting.

F7: Phantom share equivalents representing units held in the Exelon stock fund in a multi-fund, non-qualified deferred compensation plan. The Exelon stock fund is a unitized fund that consists of Exelon common stock and short term investments. Units of the fund will be settled upon the reporting person's separation from the company for any reason. Units will be settled in cash. Units are acquired through regular periodic contributions, company matching contributions and the reinvestment of dividend equivalents. The balance of phantom share equivalents may fluctuate due to periodic changes in the fund composition. Balance includes- 7 share equivalents earned through automatic dividend reinvestment.